Director of Nephrology and Hypertension at Fletcher Allen Health Care in Burlington, Vermont. Leading KOL in field of CA-AKI and principal investigator for numerous important trials. Member of the NIH consortium for AKI biomarkers.
Richard Solomon, MD
